ICRS Congress 2025 |

Boston from 11-14 October 2025.

ICRS 2025 – 18th World Congress of the International Cartilage Regeneration & Joint Preservation Society

The International Cartilage Regeneration & Joint Preservation Society (ICRS) warmly invites you to attend its 18th World Congress, taking place in Boston from October 11–14, 2025. Themed “Joint Revolution”, this congress will highlight the latest breakthroughs in cartilage repair, regeneration, and joint preservation.

Participants will have the opportunity to:

  • Discover cutting-edge basic science and clinical research,

  • Join surgical and lab workshops for hands-on learning,

  • Explore personalized strategies and precision medicine approaches for cartilage and joint care,

  • Gain insights into AI, new technologies, and global regulatory pathways.

The ICRS 2025 World Congress will bring together clinicians, surgeons, scientists, researchers, and industry partners in an interdisciplinary forum designed to foster networking, exchange of ideas, and innovation in the field of cartilage and joint preservation.

“Join us in Boston, October 11–14, 2025, for ICRS 2025: ‘Joint Revolution’. Experience cutting-edge science, surgical innovation, and cross-disciplinary collaboration to shape the future of joint preservation.”

T

Related content

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More